Impact of Lymphadenectomy on Survival in Early Stage Ovarian Germ Cell Tumors
Author Information
Author(s): Mahdi H, Swensen R E, Hanna R, Kumar S, Ali-Fehmi R, Semaan A, Tamimi H, Morris R T, Munkarah A R
Primary Institution: University of Washington School of Medicine
Hypothesis
What is the impact of lymphadenectomy and nodal metastasis on survival in clinical stage I malignant ovarian germ cell tumors?
Conclusion
Lymphadenectomy and lymph node metastasis do not independently predict survival in patients with early stage ovarian germ cell tumors confined to the ovary.
Supporting Evidence
- Out of 1083 patients, 493 underwent lymphadenectomy.
- The 5-year survival rates were 96.9% for no lymphadenectomy, 97.7% for lymphadenectomy with negative nodes, and 93.4% for lymphadenectomy with positive nodes.
- White patients were more likely to undergo lymphadenectomy compared to African-American patients.
Takeaway
The study found that removing lymph nodes during surgery for certain ovarian tumors doesn't help patients live longer.
Methodology
Data were obtained from the National Cancer Institute registry from 1988 to 2006, and analyses were performed using statistical methods including Student's t-test and Cox proportional hazard methods.
Potential Biases
Racial disparities in the likelihood of undergoing lymphadenectomy were noted.
Limitations
Lack of information on adjuvant chemotherapy, central pathology review, recurrence, and subsequent therapies.
Participant Demographics
The study included 1083 patients, predominantly young women, with a noted racial disparity in treatment.
Statistical Information
P-Value
0.5
Confidence Interval
95% CI: 0.62–2.58
Statistical Significance
p=0.5
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website